SCHEMBL30936610

SCHEMBL30936610

CN(c1ccc(Cl)cc1N)C1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.54
GAA P10253 2/20 0.54
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 3/20 0.47
RAB9A P51151 2/20 0.47
MEN1 O00255 2/20 0.47
NPC1 O15118 2/20 0.40
CYP3A4 P08684 2/20 0.39
TSHR P16473 2/20 0.38
ALOX15 P16050 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
JAK3 P52333 1/20 0.38
TP53 P04637 2/20 0.37
POLB P06746 1/20 0.37
BACE1 P56817 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30936691 0.87 ALDH1A1 (0.44) KMT2AGAAALDH1A1KDM4ERAB9A
SCHEMBL9909358 0.83 NPC1 (0.48) KMT2AGAAALDH1A1KDM4ERAB9A
SCHEMBL30936699 0.82 ALDH1A1 (0.43) GAAALDH1A1KDM4ELMNAHTT
Methylamine SCHEMBL28000433 0.81 NPC1 (0.47) KMT2AGAAALDH1A1KDM4ERAB9A
SCHEMBL16538261 0.81 ALDH1A1 (0.42) KMT2AGAAALDH1A1MEN1CYP3A4
Methylamine SCHEMBL28000600 0.80 NPC1 (0.46) KMT2AGAAALDH1A1KDM4ERAB9A
SCHEMBL20353610 0.78 KMT2A (0.46) KMT2AGAAALDH1A1KDM4ERAB9A
SCHEMBL6814037 0.77 ALDH1A1 (0.42) GAAALDH1A1RAB9ANPC1CYP3A4
Nitrogen SCHEMBL10788138 0.77 NPC1 (0.43) KMT2AGAAALDH1A1KDM4ERAB9A
SCHEMBL8564451 0.76 GAA (0.41) KMT2AGAAALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof NINE SQUARE THERAPEUTICS CORPORATION (US) 2025-11-06 US disclosed
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof TRPM2, TRPM6, TRPM5 KMT2A 2049/4885GAA 627/4885ALDH1A1 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.